Skip to main content

Table 1 Patient Characteristics

From: Diagnostic performance of an immunoassay based on urine exfoliated cell enrichment nanotechnology for upper tract urothelial carcinoma: a retrospective, monocentric study

Clinicopathologic features

UTUC

Control

Patients, n

60

40

Population

Asian

Asian

Gender, n (%)

  

 Male

38 (63.3)

27 (67.5)

 Female

22 (36.7)

13 (32.5)

Median age, years (range)

69 (46–89)

47 (25–71)

BMI (kg/m²), mean ± SD

25.3 ± 1.7

26.1 ± 2.4

Current smoking, n (%)

25 (41.7)

12 (30)

Hypertension, n (%)

21 (35)

9 (22.5)

Diabetes mellitus, n (%)

11 (18.3)

4 (10)

Pathology

 

Diagnosis

No.

 Low-grade

8 (13.3)

kidney stones

15

 High-grade

52 (86.7)

ureteral stones

15

Stage, n (%)

 

renal cyst

5

pTa

7 (11.7)

pyelonephritis

3

pTis

2 (3.3)

UPJ obstruction

2

pT1

17 (28.3)

-

pT2

5 (8.3)

-

pT3

26 (43.3)

-

pT4

3 (5)

-

  1. UTUC = upper urinary tract carcinoma; UPJ = ureteropelvic junction; no. = number; BMI = Body Mass Index